Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- CheckyesterdayChange DetectedThe page now uses the accented name ‘México’ instead of ‘Mexico’; version updated from v3.0.1 to v3.0.2; and the 'Back to Top' link has been removed.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check15 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed drug information for elafibranor and related topics such as Fatty Liver Disease and Drug Safety.SummaryDifference9%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.